Targeting platelet-derived CXCL12 impedes arterial thrombosis

Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease

(2021) Philipp von Hundelshausen et al.   Cancers

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease

(2021) Katharina Mayer et al.   JAMA Cardiology

Assessment of a complete and classified platelet proteome from genome-wide transcripts of human platelets and megakaryocytes covering platelet functions

(2021) Jingnan Huang et al.   Scientific Reports

Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time

(2021) Rundan Duan et al.   Frontiers in Cardiovascular Medicine

Chemokines and galectins form heterodimers to modulate inflammation

(2020) Veit Eckardt et al.   EMBO REPORTS

Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

(2020) Daniela Angst et al.   JOURNAL OF MEDICINAL CHEMISTRY

Functional significance of the platelet immune receptors GPVI and CLEC-2

(2019) Julie Rayes et al.   JOURNAL OF CLINICAL INVESTIGATION

CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease

(2019) Yvonne Döring et al.   CIRCULATION

Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis

(2019) Tessa J. Barrett et al.   Science Translational Medicine

Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans

(2018) Kristina Busygina et al.   BLOOD

Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation

(2018) Julia Novotny et al.   PLoS One

Biased antagonism of CXCR4 avoids antagonist tolerance

(2018) Ben Hitchinson et al.   Science Signaling

SDF-1α/CXCR4 Signaling in Lipid Rafts Induces Platelet Aggregation via PI3 Kinase-Dependent Akt Phosphorylation

(2017) Hiroko Ohtsuka et al.   PLoS One

Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation

(2017) Philipp von Hundelshausen et al.   Science Translational Medicine

CXCL12 regulates platelet activation via the regulator of G-protein signaling 16

(2016) Zubair A. Karim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Cholesterol in platelet biogenesis and activation

(2016) N. Wang et al.   BLOOD

SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4

(2015) Tony G. Walsh et al.   CELLULAR SIGNALLING

Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies

(2015) Janina Jamasbi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia

(2015) S-S Chen et al.   LEUKEMIA

Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration

(2015) Shahin Rafii et al.   NATURE CELL BIOLOGY

Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4–CXCR7

(2015) M Chatterjee et al.   Cell Death & Disease

Identification of platelet function defects by multi-parameter assessment of thrombus formation

(2014) Susanne M. de Witt et al.   Nature Communications

Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12

(2013) A Vater et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery

(2013) D. Rath et al.   EUROPEAN HEART JOURNAL

Platelet-derived CXCL12 (SDF-1α): basic mechanisms and clinical implications

(2013) M. Chatterjee et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet chemokines in health and disease

(2013) Ela Karshovska et al.   THROMBOSIS AND HAEMOSTASIS

Platelet secretion is kinetically heterogeneous in an agonist-responsive manner

(2012) D. Jonnalagadda et al.   BLOOD

Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli

(2011) M. Chatterjee et al.   BLOOD

Effect of 5-HT2A receptor antagonists on human platelet activation in blood exposed to physiologic stimuli and atherosclerotic plaque

(2011) V. G. BAMPALIS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Arterial thrombosis—insidious, unpredictable and deadly

(2011) Shaun P Jackson   NATURE MEDICINE

Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways

(2011) L. J. Drury et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4

(2009) Veronique Bodart et al.   BIOCHEMICAL PHARMACOLOGY

Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo

(2008) Christian Schulz et al.   BASIC RESEARCH IN CARDIOLOGY